Bacterio Logix LLC

BacterioLogix is at the forefront of innovative biotechnological solutions, leveraging gene editing techniques, specifically CRISPR Cas9, to transform the food stream and combat bacterial infections through phage therapy. Their approach utilizes bacteriophages—natural viruses that specifically target bacteria—offering a potentially beneficial alternative to traditional antibiotics while maintaining the delicate balance of the microbiome.

With a commitment to advancing research and development, BacterioLogix focuses on harnessing the power of genetic modifications to enhance food ingredients and tackle critical health challenges, including those posed by antibiotic-resistant bacteria. Their mission reflects a dedication to improving lives through scientific innovation and a deeper understanding of microbial ecosystems.

Generated from the website